We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen


The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”
read more

Source: NY Times


20:54, December 29, 2022 Pam Belluck

You may also like

News